Brainstem cavernous malformations

O. Petr, G. Lanzino

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Of all cavernous malformations (CMs), 4% to 35% are found in the brainstem accounting for 13% of vascular malformations of the posterior fossa. The annual risk of hemorrhage associated with a CM with no history of a previous hemorrhagic episode is very low ranging from 0.6% to 1.1% per year. However, the risk of recurrent hemorrhage after a presenting bleed is signiicantly higher. There is a correlation between the extent of persistent neurological deicits and the number of recurrent hemorrhages as rehemorrhage increases the rate and severity of neurological deicits. Neurological deicits often improve after a hemorrhagic event spontaneously and sometimes resolve completely. The indication for surgery in patients with brainstem CMs is controversial. Over the years, we have taken a more cautious stance and we often recommend observation in patients after a single symptomatic bleed as most patients return to a good level of functioning after a single bleed. Surgery is recommended for more aggressive lesions usually after a recurrent bleed. In general, given the very low risk of bleeding from truly asymptomatic lesions, surgery should not be considered in these patients. For symptomatic lesions which have presented with hemorrhage, the decision of whether or not to proceed with surgical resection is related to the risk of surgery, patient's disposition and perceived risk of rebleeding. Favorable outcome can be achieved through surgical resection after an appropriate selection of the patients and thorough preoperative surgical planning.

Original languageEnglish (US)
Pages (from-to)271-282
Number of pages12
JournalJournal of Neurosurgical Sciences
Volume59
Issue number3
StatePublished - Sep 1 2015

Fingerprint

Brain Stem
Hemorrhage
Vascular Malformations
Patient Selection
Observation

Keywords

  • Cavernous
  • Central nervous system
  • Hemangioma
  • Hemorrhage
  • Microsurgery

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Medicine(all)

Cite this

Petr, O., & Lanzino, G. (2015). Brainstem cavernous malformations. Journal of Neurosurgical Sciences, 59(3), 271-282.

Brainstem cavernous malformations. / Petr, O.; Lanzino, G.

In: Journal of Neurosurgical Sciences, Vol. 59, No. 3, 01.09.2015, p. 271-282.

Research output: Contribution to journalArticle

Petr, O & Lanzino, G 2015, 'Brainstem cavernous malformations', Journal of Neurosurgical Sciences, vol. 59, no. 3, pp. 271-282.
Petr O, Lanzino G. Brainstem cavernous malformations. Journal of Neurosurgical Sciences. 2015 Sep 1;59(3):271-282.
Petr, O. ; Lanzino, G. / Brainstem cavernous malformations. In: Journal of Neurosurgical Sciences. 2015 ; Vol. 59, No. 3. pp. 271-282.
@article{0b6ec386f07443b9b8af57db4681128f,
title = "Brainstem cavernous malformations",
abstract = "Of all cavernous malformations (CMs), 4{\%} to 35{\%} are found in the brainstem accounting for 13{\%} of vascular malformations of the posterior fossa. The annual risk of hemorrhage associated with a CM with no history of a previous hemorrhagic episode is very low ranging from 0.6{\%} to 1.1{\%} per year. However, the risk of recurrent hemorrhage after a presenting bleed is signiicantly higher. There is a correlation between the extent of persistent neurological deicits and the number of recurrent hemorrhages as rehemorrhage increases the rate and severity of neurological deicits. Neurological deicits often improve after a hemorrhagic event spontaneously and sometimes resolve completely. The indication for surgery in patients with brainstem CMs is controversial. Over the years, we have taken a more cautious stance and we often recommend observation in patients after a single symptomatic bleed as most patients return to a good level of functioning after a single bleed. Surgery is recommended for more aggressive lesions usually after a recurrent bleed. In general, given the very low risk of bleeding from truly asymptomatic lesions, surgery should not be considered in these patients. For symptomatic lesions which have presented with hemorrhage, the decision of whether or not to proceed with surgical resection is related to the risk of surgery, patient's disposition and perceived risk of rebleeding. Favorable outcome can be achieved through surgical resection after an appropriate selection of the patients and thorough preoperative surgical planning.",
keywords = "Cavernous, Central nervous system, Hemangioma, Hemorrhage, Microsurgery",
author = "O. Petr and G. Lanzino",
year = "2015",
month = "9",
day = "1",
language = "English (US)",
volume = "59",
pages = "271--282",
journal = "Journal of Neurosurgical Sciences",
issn = "0026-4881",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Brainstem cavernous malformations

AU - Petr, O.

AU - Lanzino, G.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Of all cavernous malformations (CMs), 4% to 35% are found in the brainstem accounting for 13% of vascular malformations of the posterior fossa. The annual risk of hemorrhage associated with a CM with no history of a previous hemorrhagic episode is very low ranging from 0.6% to 1.1% per year. However, the risk of recurrent hemorrhage after a presenting bleed is signiicantly higher. There is a correlation between the extent of persistent neurological deicits and the number of recurrent hemorrhages as rehemorrhage increases the rate and severity of neurological deicits. Neurological deicits often improve after a hemorrhagic event spontaneously and sometimes resolve completely. The indication for surgery in patients with brainstem CMs is controversial. Over the years, we have taken a more cautious stance and we often recommend observation in patients after a single symptomatic bleed as most patients return to a good level of functioning after a single bleed. Surgery is recommended for more aggressive lesions usually after a recurrent bleed. In general, given the very low risk of bleeding from truly asymptomatic lesions, surgery should not be considered in these patients. For symptomatic lesions which have presented with hemorrhage, the decision of whether or not to proceed with surgical resection is related to the risk of surgery, patient's disposition and perceived risk of rebleeding. Favorable outcome can be achieved through surgical resection after an appropriate selection of the patients and thorough preoperative surgical planning.

AB - Of all cavernous malformations (CMs), 4% to 35% are found in the brainstem accounting for 13% of vascular malformations of the posterior fossa. The annual risk of hemorrhage associated with a CM with no history of a previous hemorrhagic episode is very low ranging from 0.6% to 1.1% per year. However, the risk of recurrent hemorrhage after a presenting bleed is signiicantly higher. There is a correlation between the extent of persistent neurological deicits and the number of recurrent hemorrhages as rehemorrhage increases the rate and severity of neurological deicits. Neurological deicits often improve after a hemorrhagic event spontaneously and sometimes resolve completely. The indication for surgery in patients with brainstem CMs is controversial. Over the years, we have taken a more cautious stance and we often recommend observation in patients after a single symptomatic bleed as most patients return to a good level of functioning after a single bleed. Surgery is recommended for more aggressive lesions usually after a recurrent bleed. In general, given the very low risk of bleeding from truly asymptomatic lesions, surgery should not be considered in these patients. For symptomatic lesions which have presented with hemorrhage, the decision of whether or not to proceed with surgical resection is related to the risk of surgery, patient's disposition and perceived risk of rebleeding. Favorable outcome can be achieved through surgical resection after an appropriate selection of the patients and thorough preoperative surgical planning.

KW - Cavernous

KW - Central nervous system

KW - Hemangioma

KW - Hemorrhage

KW - Microsurgery

UR - http://www.scopus.com/inward/record.url?scp=84974785741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974785741&partnerID=8YFLogxK

M3 - Article

C2 - 25943871

AN - SCOPUS:84974785741

VL - 59

SP - 271

EP - 282

JO - Journal of Neurosurgical Sciences

JF - Journal of Neurosurgical Sciences

SN - 0026-4881

IS - 3

ER -